Donor lymphocyte infusion as therapy for persistent pure red cell aplasia following major ABO-incompatible stem cell transplantation

被引：0
|
作者：
Lubking, A. [1 ]
Winqvist, I. [1 ]
Lenhoff, S. [1 ]
机构：
[1] Lund Univ, Lund, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S373 / S373
页数：1
相关论文
共 50 条
  • [21] Rituximab for pure red cell aplasia after ABO incompatible allogeneic stem cell transplantation
    De Matteis, S
    Sorà, F
    Laurenti, L
    Chiusolo, P
    Zini, G
    Piccirillo, N
    Farina, G
    Tamani, M
    Leone, G
    Sica, S
    BONE MARROW TRANSPLANTATION, 2004, 33 : S341 - S341
  • [22] Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation
    Gao, Yang
    Gao, Fei
    Shi, Jimin
    Fu, Huarui
    Huang, He
    Zhao, Yanmin
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2021, 22 (08): : 695 - 700
  • [23] PURE RED-CELL APLASIA OF LONG DURATION AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION
    VOLIN, L
    RUUTU, T
    ACTA HAEMATOLOGICA, 1990, 84 (04) : 195 - 197
  • [24] PURE RED-CELL APLASIA OF LONG DURATION COMPLICATING MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION
    GMUR, JP
    BURGER, J
    SCHAFFNER, A
    NEFTEL, K
    OELZ, O
    FREY, D
    METAXAS, M
    BLOOD, 1990, 75 (01) : 290 - 295
  • [25] Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation
    Tomac, Gordana
    Bojarnic, Ines
    Mazic, Sanja
    Vidovic, Ivana
    Raos, Mirela
    Cepulic, Branka Golubic
    Seiwerth, Ranka Serventi
    Kelecic, Jadranka
    Labar, Boris
    BLOOD TRANSFUSION, 2018, 16 (04) : 397 - 404
  • [26] Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation
    Malfuson, J-V.
    Amor, R. B.
    Bonin, P.
    Rodet, M.
    Boccaccio, C.
    Pautas, C.
    Kuentz, M.
    Cordonnier, C.
    Noizat-Pirenne, F.
    Maury, S.
    VOX SANGUINIS, 2007, 92 (01) : 85 - 89
  • [27] Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors
    Hirokawa, Makoto
    Fukuda, Takahiro
    Ohashi, Kazuteru
    Hidaka, Michihiro
    Ichinohe, Tatsuo
    Iwato, Koji
    Kanamori, Heiwa
    Murata, Makoto
    Sakura, Toru
    Imamura, Masahiro
    Adachi, Soichi
    Suzuki, Ritsuro
    Morishima, Yasuo
    Sakamaki, Hisashi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1026 - 1032
  • [28] Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question
    Javier Marco-Ayala
    Inés Gómez-Seguí
    Guillermo Sanz
    Pilar Solves
    Bone Marrow Transplantation, 2021, 56 : 769 - 778
  • [29] Treatment of Pure Red Cell Aplasia after Major ABO Incompatible Allogenic Stem Cell Transplantation: A French Retrospective Study
    Longval, Thomas
    Galimard, Jacques-Emmanuel
    Lepretre, Anne-Claire
    Suarez, Felipe
    Amiranoff, Denise
    Cazaux, Marine
    Michonneau, David
    Coman, Tereza
    Bourhis, Jean-Henri
    Quoc, Stephanie Nguyen
    Kaphan, Eleonore
    Socie, Gerard
    de Latour, Regis Peffault
    Resche-Rigon, Matthieu
    de Fontbrune, Flore Sicre
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 392 - 393
  • [30] Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question
    Marco-Ayala, Javier
    Gomez-Segui, Ines
    Sanz, Guillermo
    Solves, Pilar
    BONE MARROW TRANSPLANTATION, 2021, 56 (04) : 769 - 778
12345